Equifax (EFX) Stock Forecast & Price Target

Q: What analysts cover Equifax?

Equifax has been rated by research analysts at Argus , Barclays , BMO Capital Markets , Credit Suisse Group , Deutsche Bank Aktiengesellschaft , Loop Capital , Mizuho , Morgan Stanley , Needham & Company LLC , Oppenheimer , Rothschild & Co Redburn , Royal Bank Of Canada , Stifel Nicolaus , The Goldman Sachs Group , UBS Group , Weiss Ratings , and Wells Fargo & Company in the past 90 days.

$187.26 +11.69 (+6.66%)

Closing price 10/22/2026 03:59 PM Eastern

Extended Trading

$186.79 -0.47 (-0.25%)

As of 10/22/2026 07:45 PM Eastern

Compare

Equifax - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Moderate Buy

Based on 21 Analyst Ratings

Sell
0

Hold
6

Buy
15

Based on 21 Wall Street analysts who have issued ratings for Equifax in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 21 analysts, 6 have given a hold rating, and 15 have given a buy rating for EFX.

Consensus Price Target

$200.00
6.81% Upside

According to the 21 analysts' twelve-month price targets for Equifax, the average price target is $200.00. The highest price target for EFX is $266.00, while the lowest price target for EFX is $148.00. The average price target represents a forecasted upside of 6.81% from the current price of $187.26.

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Get the Latest News and Ratings for EFX and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Equifax and its competitors.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

EFX Analyst Ratings Over Time

Type	Current Forecast 10/23/25 to 10/23/26	1 Month Ago 9/23/25 to 9/23/26	3 Months Ago 7/25/25 to 7/25/26	1 Year Ago 10/23/24 to 10/23/25
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	1 Strong Buy rating(s)
Buy	15 Buy rating(s)	15 Buy rating(s)	14 Buy rating(s)	12 Buy rating(s)
Hold	6 Hold rating(s)	6 Hold rating(s)	6 Hold rating(s)	7 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$200.00	$214.53	$214.05	$277.13
Forecasted Upside	6.81% Upside	38.35% Upside	24.39% Upside	19.81% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy

EFX Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

EFX Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Equifax Stock vs. The Competition

Type	Equifax	Industrials Companies	Broader Market
Consensus Rating Score	2.71	2.30	2.53
Consensus Rating	Moderate Buy	Hold	Moderate Buy
Predicted Upside	6.81% Upside	140.97% Upside	15.78% Upside
News Sentiment Rating	Positive News See Recent EFX News	Neutral News	Positive News

Recent Analyst Forecasts and Stock Ratings

Show

Rating

Upside/Downside

Action

Report Date

0 Results

Export

Date	Brokerage	Analyst	Action	Rating	Price Target	Report Date Upside/Downside
10/22/2026	Argus 3 of 5 stars	John Eade 1 of 5 stars	Upgrade	Hold ➝ Buy	$200.00	+13.99%
10/21/2026	BMO Capital Markets 3 of 5 stars	Ryan Griffin Not Rated	Boost Target	Market Perform	$160.00 ➝ $175.00	-0.93%
10/21/2026	UBS Group 4 of 5 stars	Kevin McVeigh 1 of 5 stars	Reiterated Rating	Buy
10/21/2026	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access to unlock brokerage rankings	Faiza Alwy Subscribe to MarketBeat All Access to unlock analyst rankings	Reiterated Rating	Buy	$201.00	+13.79%
10/21/2026	Stifel Nicolaus Subscribe to MarketBeat All Access to unlock brokerage rankings	Shlomo Rosenbaum Subscribe to MarketBeat All Access to unlock analyst rankings	Lower Target	Buy	$235.00 ➝ $217.00	+22.52%
10/21/2026	Needham & Company LLC Subscribe to MarketBeat All Access to unlock brokerage rankings	Kyle Peterson Subscribe to MarketBeat All Access to unlock analyst rankings	Boost Target	Buy	$190.00 ➝ $210.00	+18.56%
10/20/2026	Loop Capital Subscribe to MarketBeat All Access to unlock brokerage rankings		Set Target		$169.00	-4.59%
10/20/2026	The Goldman Sachs Group Subscribe to MarketBeat All Access to unlock brokerage rankings	George Tong Subscribe to MarketBeat All Access to unlock analyst rankings	Reiterated Rating	Neutral
10/19/2026	Mizuho Subscribe to MarketBeat All Access to unlock brokerage rankings	Sean Kennedy Subscribe to MarketBeat All Access to unlock analyst rankings	Lower Target	Outperform	$210.00 ➝ $185.00	+14.76%
10/16/2026	Royal Bank Of Canada Subscribe to MarketBeat All Access to unlock brokerage rankings	Ashish Sabadra Subscribe to MarketBeat All Access to unlock analyst rankings	Lower Target	Outperform	$194.00 ➝ $177.00	+10.03%
Get the Latest News and Ratings for EFX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Equifax and its competitors with MarketBeat's FREE daily newsletter.
10/16/2026	Oppenheimer Subscribe to MarketBeat All Access to unlock brokerage rankings	Rayna Kumar Subscribe to MarketBeat All Access to unlock analyst rankings	Downgrade	Outperform ➝ Market Perform
10/13/2026	Morgan Stanley Subscribe to MarketBeat All Access to unlock brokerage rankings	Toni Kaplan Subscribe to MarketBeat All Access to unlock analyst rankings	Lower Target	Overweight	$225.00 ➝ $205.00	+38.51%
10/2/2026	Barclays Subscribe to MarketBeat All Access to unlock brokerage rankings	Manav Patnaik Subscribe to MarketBeat All Access to unlock analyst rankings	Lower Target	Equal Weight	$200.00 ➝ $155.00	+11.01%
9/30/2026	Credit Suisse Group Subscribe to MarketBeat All Access to unlock brokerage rankings		Set Target		$160.00	+13.80%
9/22/2026	Wells Fargo & Company Subscribe to MarketBeat All Access to unlock brokerage rankings	Jason Haas Subscribe to MarketBeat All Access to unlock analyst rankings	Lower Target	Overweight	$212.00 ➝ $200.00	+25.87%
8/21/2026	Rothschild & Co Redburn Subscribe to MarketBeat All Access to unlock brokerage rankings	Simon Clinch Subscribe to MarketBeat All Access to unlock analyst rankings	Upgrade	Neutral ➝ Buy	$214.00 ➝ $235.00	+22.27%
8/13/2026	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings		Upgrade	Sell (D+) ➝ Hold (C-)
7/22/2026	Robert W. Baird Subscribe to MarketBeat All Access to unlock brokerage rankings	Jeffrey Meuler Subscribe to MarketBeat All Access to unlock analyst rankings	Lower Target	Outperform	$245.00 ➝ $232.00	+34.70%
7/22/2026	Citigroup Subscribe to MarketBeat All Access to unlock brokerage rankings		Lower Target	Buy	$238.00 ➝ $220.00	+18.25%
7/22/2026	BNP Paribas Exane Subscribe to MarketBeat All Access to unlock brokerage rankings		Boost Target	Neutral	$185.00 ➝ $190.00	+2.12%
7/22/2026	JPMorgan Chase & Co. Subscribe to MarketBeat All Access to unlock brokerage rankings		Lower Target		$230.00 ➝ $210.00	+12.87%
5/19/2026	Bank of America Subscribe to MarketBeat All Access to unlock brokerage rankings	Curtis Nagle Subscribe to MarketBeat All Access to unlock analyst rankings	Lower Target	Buy	$250.00 ➝ $225.00	+40.19%
4/24/2026	Jefferies Financial Group Subscribe to MarketBeat All Access to unlock brokerage rankings		Lower Target	Buy	$220.00 ➝ $200.00	+16.12%
2/18/2025	Gordon Haskett Subscribe to MarketBeat All Access to unlock brokerage rankings	Chuck Grom Subscribe to MarketBeat All Access to unlock analyst rankings	Upgrade	Strong-Buy
2/7/2025	William Blair Subscribe to MarketBeat All Access to unlock brokerage rankings		Reiterated Rating	Outperform
12/12/2024	Wolfe Research Subscribe to MarketBeat All Access to unlock brokerage rankings	Scott Wurtzel Subscribe to MarketBeat All Access to unlock analyst rankings	Downgrade	Outperform ➝ Peer Perform

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 01:14 AM ET.

Should I Buy Equifax Stock? EFX Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Tuesday, October 20, 2026. Please send any questions or comments about these Equifax pros and cons to contact@marketbeat.com.

Equifax
Bull Case

Here are some ways that investors could benefit from investing in Equifax Inc.:

Equifax Inc. reported third-quarter 2026 adjusted earnings per share of $2.26, which exceeded the analyst consensus estimate of $2.20 and represented an 11% increase from the same period last year, demonstrating strong profitability despite market headwinds.
The company's diversified markets revenue grew by more than 8% in the third quarter, outperforming the mid-single-digit outlook, while adjusted EBITDA margins excluding FICO expanded by 130 basis points year over year due to operating leverage and AI-related productivity initiatives.
Equifax Inc. is set to close its $750 million acquisition of Mexico-based credit bureau Círculo de Crédito in the fourth quarter, a move expected to be accretive to adjusted earnings per share in the first full year of ownership and expand the company's international footprint.
Adoption of VantageScore 4.0 has accelerated significantly, with approximately 2,000 mortgage lenders using the score in underwriting processes, up sevenfold since April, and management estimates that full conversion from FICO scores would provide roughly $35 million in incremental margin at current activity levels.
Following the strong earnings report, the stock price gapped up to $177.12, reflecting a positive market reaction to the company's ability to maintain growth in non-mortgage segments and its commitment to returning capital to shareholders, including over $1 billion in expected free cash flow for 2026.

Equifax
Bear Case

Investors should be bearish about investing in Equifax Inc. for these reasons:

The U.S. mortgage market has weakened significantly, with 30-year fixed mortgage rates rising to roughly 7.5% in September, causing the company to lower its full-year U.S. mortgage revenue forecast by about $80 million relative to its July outlook.
Equifax Inc. expects fourth-quarter mortgage revenue to decline by a mid-single-digit percentage year over year, with mortgage revenue excluding FICO royalty-related revenue expected to fall by a mid-double-digit percentage, indicating continued pressure on this key revenue stream.
The company faces a potential annual revenue impact of about $80 million if the industry moves from tri-merge mortgage credit reports to a two-bureau model, a structural change that could reduce demand for its traditional credit reporting services.
Despite the recent earnings beat, the stock price of $177.12 remains well below its 52-week high of $238.94, reflecting a significant decline in valuation over the past year that may indicate lingering investor concerns about the company's long-term growth trajectory.
Management projects that 2027 mortgage-market transactions will decline by a high-single-digit percentage from 2026 levels, with the bulk of the decline expected in the first eight months of the year, suggesting that the headwinds in the housing sector are likely to persist into the next fiscal year.

EFX Forecast - Frequently Asked Questions

According to the research reports of 21 Wall Street equities research analysts, the average twelve-month stock price forecast for Equifax is $200.00, with a high forecast of $266.00 and a low forecast of $148.00.

21 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Equifax in the last year. There are currently 6 hold ratings and 15 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" EFX shares.

According to analysts, Equifax's stock has a predicted upside of 6.81% based on their 12-month stock forecasts.

Over the previous 90 days, Equifax's stock had 3 upgrades and 2 downgrades by analysts.

Equifax has been rated by research analysts at Argus, Barclays, BMO Capital Markets, Credit Suisse Group, Deutsche Bank Aktiengesellschaft, Loop Capital, Mizuho, Morgan Stanley, Needham & Company LLC, Oppenheimer, Rothschild & Co Redburn, Royal Bank Of Canada, Stifel Nicolaus, The Goldman Sachs Group, UBS Group, Weiss Ratings, and Wells Fargo & Company in the past 90 days.

Analysts like Equifax more than other "industrials" companies. The consensus rating for Equifax is Moderate Buy while the average consensus rating for "industrials" companies is Hold. Learn more on how EFX compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Equifax Recommendations

MarketBeat monitors more than a dozen sources for Equifax analyst ratings, with the most recent rating issued on 10/22/2026.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Equifax (EFX) Stock Forecast & Price Target